Liquid Biopsy Market Research 2024: Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook 2023-2027.
| Published date | 27 March 2024 |
M2 PRESSWIRE-March 27, 2024-: Liquid Biopsy Market Research 2024: Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook 2023-2027
(C)1994-2024 M2 COMMUNICATIONS
RDATE:27032024
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to ResearchAndMarkets.com's offering.
The Screening, Diagnostic, Therapy Selection, Minimal Residual Disease and Screening Market Potential are all explored in this report. What is the impact of the COVID pandemic on the Liquid Biopsy market? We look at Price and Volume Outlooks by type of cancer. This report provides detailed analysis.
Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test.
Illumina is now working on the Circulating Cell-Free Genome Atlas (CCGA) to help identify cancer early. Technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has just moved out of the development phase and into the growth phase. The impact on the healthcare industry is enormous. The report forecasts the market size looking out 5 years. In addition, the report looks at potential market sizes by country, by cancer and by the four types of usage: screening, diagnosis, therapy selection and recurrence monitoring.
The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitoring. Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
1 Market Guides1.1 Liquid Biopsy Market - Strategic Situation Analysis1.2 Guide for Executives, Marketing, Sales and Business Development Staff1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and...
To continue reading
Request your trial